辉瑞研发新冠疫苗增强剂，以应对德尔塔变异病毒

42
7
Favorite

辉瑞研发新冠疫苗增强剂，以应对德尔塔变异病毒

新浪财经2021-07-09

辉瑞及其合作伙伴BioNTech周四宣布，他们正开发一种针对“德尔塔”变种病毒的新冠疫苗增强剂，因为人们越来越担心这种高度传染性的毒株已经成为美国新冠病毒的主要毒株。两家公司表示，尽管他们认为目前的两剂疫苗如果施打第三剂有可能对包括德尔塔在内的所有已知变种保持“最高水平”的保护，但他们仍在“保持警惕”，并正在开发一种更新版本的疫苗。两家公司表示，临床研究最早可能于8月开始，但需获得监管机构的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（7）

EliTan
·2021-07-09
Good
Reply
1
Report
Fold Replies
- EliTan:
  hao
  2021-07-09
  Reply
  Report
EliTan
·2021-07-09
Good
Reply
1
Report
HuiYin296
·2021-07-09
??
Reply
1
Report
甜甜圈大
·2021-07-09
加油
Reply
2
Report
Jessie8590
·2021-07-09
[微笑]
Reply
2
Report
Kenny52041
·2021-07-09
power~~
Reply
1
Report
Eileen1026
·2021-07-09
????
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1106457456?lang=en_US&edition=fundamental","thumbnail":"https://static.tigerbbs.com/f78fc8716e758c96a05271f4a9570166","is_english":false,"pubTime":"2021-07-09 07:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106457456","market":"us","top_or_hot":-1,"title":"辉瑞研发新冠疫苗增强剂，以应对德尔塔变异病毒","media":"新浪财经","content":"<div>\n<p>辉瑞及其合作伙伴BioNTech周四宣布，他们正开发一种针对“德尔塔”变种病毒的新冠疫苗增强剂，因为人们越来越担心这种高度传染性的毒株已经成为美国新冠病毒的主要毒株。\n两家公司表示，尽管他们认为目前的两剂疫苗如果施打第三剂有可能对包括德尔塔在内的所有已知变种保持“最高水平”的保护，但他们仍在“保持警惕”，并正在开发一种更新版本的疫苗。\n两家公司表示，临床研究最早可能于8月开始，但需获得监管机构的...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-07-09/doc-ikqcfnca5780249.shtml\">Source Link</a>\n\n</div>\n","source":"XLCJ","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>辉瑞研发新冠疫苗增强剂，以应对德尔塔变异病毒</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n辉瑞研发新冠疫苗增强剂，以应对德尔塔变异病毒\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 07:14 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2021-07-09/doc-ikqcfnca5780249.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>辉瑞及其合作伙伴BioNTech周四宣布，他们正开发一种针对“德尔塔”变种病毒的新冠疫苗增强剂，因为人们越来越担心这种高度传染性的毒株已经成为美国新冠病毒的主要毒株。\n两家公司表示，尽管他们认为目前的两剂疫苗如果施打第三剂有可能对包括德尔塔在内的所有已知变种保持“最高水平”的保护，但他们仍在“保持警惕”，并正在开发一种更新版本的疫苗。\n两家公司表示，临床研究最早可能于8月开始，但需获得监管机构的...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-07-09/doc-ikqcfnca5780249.shtml\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PFE","symbol_name":"辉瑞","start_time":0,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-07-09/doc-ikqcfnca5780249.shtml","article_id":"1106457456","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/f78fc8716e758c96a05271f4a9570166"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106457456","pubTimestamp":1625786090,"sourceInfo":{"source_id":"XLCJ","name":"新浪财经"},"weMediaInfo":null,"summary":"辉瑞及其合作伙伴BioNTech周四宣布，他们正开发一种针对“德尔塔”变种病毒的新冠疫苗增强剂，因为人们越来越担心这种高度传染性的毒株已经成为美国新冠病毒的主要毒株。\n两家公司表示，尽管他们认为目前的","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PFE":"辉瑞"},"translate_title":"Pfizer develops COVID-19 vaccine booster to deal with Delta variant virus","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/189bf88014cdb12f0d62daa681c1d5cd","symbols_score_info":{"PFE":0.9},"content_text":"辉瑞及其合作伙伴BioNTech周四宣布，他们正开发一种针对“德尔塔”变种病毒的新冠疫苗增强剂，因为人们越来越担心这种高度传染性的毒株已经成为美国新冠病毒的主要毒株。\n两家公司表示，尽管他们认为目前的两剂疫苗如果施打第三剂有可能对包括德尔塔在内的所有已知变种保持“最高水平”的保护，但他们仍在“保持警惕”，并正在开发一种更新版本的疫苗。\n两家公司表示，临床研究最早可能于8月开始，但需获得监管机构的批准。","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":143637010,"gmtCreate":1625791159030,"gmtModify":1703748546984,"author":{"id":"3586177722241250","authorId":"3586177722241250","name":"EliTan","avatar":"https://static.tigerbbs.com/a52c68e0b84d7f61c9d9ccf225bb2bb8","vip":1,"crmLevel":8,"crmLevelSwitch":0,"idStr":"3586177722241250","authorIdStr":"3586177722241250"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/143637010","repostId":1106457456,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5166687,"gmtCreate":1625791168830,"gmtModify":1635233730785,"authorId":3586177722241250,"author":{"id":3586177722241250,"idStr":"3586177722241250","authorId":3586177722241250,"name":"EliTan","avatar":"https://static.tigerbbs.com/a52c68e0b84d7f61c9d9ccf225bb2bb8","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"93.37%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":8,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":143637010,"type":1,"supId":0,"prevId":0,"content":"hao","text":"hao","html":"hao"}],"langContent":"EN"},{"id":143634145,"gmtCreate":1625791144987,"gmtModify":1703748546170,"author":{"id":"3586177722241250","authorId":"3586177722241250","name":"EliTan","avatar":"https://static.tigerbbs.com/a52c68e0b84d7f61c9d9ccf225bb2bb8","vip":1,"crmLevel":8,"crmLevelSwitch":0,"idStr":"3586177722241250","authorIdStr":"3586177722241250"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143634145","repostId":1106457456,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143852513,"gmtCreate":1625789048032,"gmtModify":1703748472517,"author":{"id":"3586462546387284","authorId":"3586462546387284","name":"HuiYin296","avatar":"https://static.tigerbbs.com/14138ba07671079f0f27a369bf95544c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3586462546387284","authorIdStr":"3586462546387284"},"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143852513","repostId":1106457456,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143858121,"gmtCreate":1625788958763,"gmtModify":1703748468606,"author":{"id":"3582620232503939","authorId":"3582620232503939","name":"甜甜圈大","avatar":"https://static.tigerbbs.com/49a5dbe8cbe156875b45e24460604fbc","vip":1,"hat":"https://static.tigerbbs.com/622fc56f7e67b5729addb4e78a195511","crmLevel":2,"crmLevelSwitch":0,"idStr":"3582620232503939","authorIdStr":"3582620232503939"},"htmlText":"加油","listText":"加油","text":"加油","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143858121","repostId":1106457456,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":143824850,"gmtCreate":1625788748670,"gmtModify":1703748459221,"author":{"id":"3571194868777759","authorId":"3571194868777759","name":"Jessie8590","avatar":"https://community-static.tradeup.com/news/ae62e8ad7c913a19f3613c117b492985","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":3,"crmLevelSwitch":1,"idStr":"3571194868777759","authorIdStr":"3571194868777759"},"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143824850","repostId":1106457456,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":143868953,"gmtCreate":1625788064072,"gmtModify":1703748438965,"author":{"id":"3586333932625551","authorId":"3586333932625551","name":"Kenny52041","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3586333932625551","authorIdStr":"3586333932625551"},"htmlText":"power~~","listText":"power~~","text":"power~~","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143868953","repostId":1106457456,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":143817992,"gmtCreate":1625787597816,"gmtModify":1703748416755,"author":{"id":"3570339008516927","authorId":"3570339008516927","name":"Eileen1026","avatar":"https://static.tigerbbs.com/92cbc835218bdeed556152d9d1af6da8","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3570339008516927","authorIdStr":"3570339008516927"},"htmlText":"????","listText":"????","text":"????","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/143817992","repostId":1106457456,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":42,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}